Concepedia

Jeff Hsu

JH

Statistics

Publications

14

Citations

2.7K

H-Index

11

Active since

2002

Affiliations

Pharmacyclics (United States)(Current)

University of California, San Francisco

Ionis Pharmaceuticals (United States)

Southampton General Hospital

Memorial Sloan Kettering Cancer Center

Jeff Hsu is an author at Pharmacyclics (United States) specializing in medicine, cell biology, and radiation oncology.

ORCID

Top concepts

Publications per year

2002–2022

14

Publications

14

The Noncoding RNA <i>MALAT1</i> Is a Critical Regulator of the Metastasis Phenotype of Lung Cancer Cells

Tony Gutschner, Monika Hämmerle, Jeff Hsu et al. · Cancer Research · 2012 · 1.5K citations · Full text

AZD9150, a next-generation antisense oligonucleotide inhibitor of <i>STAT3</i> with early evidence of clinical activity in lymphoma and lung cancer

David S. Hong, Razelle Kurzrock, Youngsoo Kim et al. · Science Translational Medicine · 2015 · 428 citations · Full text

STAT3 antisense oligonucleotide AZD9150 in a subset of patients with heavily pretreated lymphoma: results of a phase 1b trial

Matthew J. Reilley, Patricia McCoon, Carl Cook et al. · Journal for ImmunoTherapy of Cancer · 2018 · 275 citations · Full text

A prospective randomized study to evaluate the renoprotective action of beating heart coronary surgery in low risk patients

A. Tang, J. Knott, J. Nanson et al. · European Journal of Cardio-Thoracic Surgery · 2002 · 107 citations

A functional switch from lung cancer resistance to susceptibility at the Pas1 locus in Kras2LA2 mice

Minh D. To, Jesús Pérez‐Losada, Jian‐Hua Mao et al. · Nature Genetics · 2006 · 69 citations · Full text

, , +12

Rows per page

1–5 of 14